Dato Capt. Mahesan Subramaniam/LinkedIn
Feb 23, 2026, 17:46
Mahesan Subramaniam: The Physiological Impact of Anger on Immunity
Mahesan Subramaniam, Co-Founder of United Health Tourism, shared a post on LinkedIn:
“Anger suppresses the immune system by triggering a ‘fight-or-flight’ response that floods the body with stress hormones like cortisol and adrenaline. While these hormones provide a short-term energy burst, they inhibit the production and activity of critical immune cells.
The physiological impact of anger can be broken down into several key pathways:
- Hormonal Inhibition: Elevated cortisol levels directly suppress the activity of white blood cells, including natural killer (NK) cells and lymphocytes, which are essential for fighting off viruses and abnormalities cells.
- Inflammatory Dysregulation: Anger increases the production of pro-inflammatory cytokine. Over time, this leads to chronic inflammation, which damages tissues and can trigger autoimmune disorders where the immune system attacks it own body.
- Antibody Reduction: Chronic hostility has been linked to a weakened ability to produce antibodies, increasing susceptibility to common infections like the cold or flu.
- Cellular ‘Freeze’ Response: In cases of trauma or suppressed rage, the body may stay in a constant state of alert, causing the immune system to eventually ‘collapse’ or become hyper-reactive.
While just one minute of anger can suppress the immune system, chronic or persistent anger is associated with slower wound healing, higher risks of heart disease, and a greater likelihood of developing autoimmune conditions like rheumatoid arthritis and lupus.”

Discover the latest in Hemostasis Today.
-
Apr 14, 2026, 17:32Denise M.: Surviving Sepsis 2026 – The Upstream Revolution
-
Apr 14, 2026, 17:23Meghanath Yenni։ What’s New in Acute Ischemic Stroke in 2026
-
Apr 14, 2026, 17:11Phil Spinella: What Dose of TXA for Children With Severe Traumatic Bleeding Should You Use?
-
Apr 14, 2026, 17:08Abdulrahman Katib: How Endovascular Stenting Is Transforming the Treatment of Severe PTS
-
Apr 14, 2026, 17:00Anna A. Avagyan: Glad to Be Part of EHA Pediatric Hematology-Oncology Course
-
Apr 14, 2026, 16:58Ney Carter Borges: NLRP3 Inhibition in Atherosclerosis – Early Clinical Signal Beyond Lipids
-
Apr 14, 2026, 16:56Saskia Middeldorp: Key Takeaways from the 2026 ACC/AHA Guideline on Acute PE
-
Apr 14, 2026, 16:54Chokri Ben Lamine: Extracorporeal Photopheresis for aGVHD cGVHD Post-SCT – 50 Pearls
-
Apr 14, 2026, 16:49Ahmed Magdi Omar: Key Takeaways From the Latest 2026 Guidelines on Antiplatelet Therapy in AIS